Down About 29%, Is Meta Stock a Buy, Sell, or Hold?

Meta’s Q1 revenue grew 33% year over year to $56.3 billion, up from 24% growth in Q4 2025, while operating income rose 30% to $22.9 billion and the operating margin held at 41%. Management lifted 2026 capital expenditures to $125 billion-$145 billion and total expenses to $162 billion-$169 billion, underscoring heavy AI-related spending risk. Despite the stock falling about 29% from last August’s high, the shares trade at roughly 17x next year’s expected earnings, making the article’s stance a measured buy.

Analysis

Meta’s setup is now a classic “good business, bad capex” tape. The key second-order effect is that AI spend is no longer just an investment in future monetization; it is also a growing claims on free cash flow that can mechanically suppress per-share comp for multiple quarters even if revenue remains strong. That matters because the market can tolerate high spend when returns are visible, but it usually compresses the multiple when management keeps revising the required compute budget upward faster than the revenue bridge can prove out.

The near-term winners are the infrastructure providers tied to capacity buildout, while the losers are vendors exposed to any future moderation in spend if Meta decides the ROI is lagging. The more interesting competitive dynamic is that Meta’s improved ad performance implies its AI stack is already working operationally, which raises the bar for peers: smaller ad platforms may not have the scale to match the same data-center intensity, and ad-tech names with weaker targeting engines could see share losses as Meta widens the quality gap.

The main risk is not that Meta is expensive; it is that the market is underestimating the duration of elevated depreciation and the possibility that capital intensity stays structurally higher for years. If revenue growth decelerates even modestly while capex remains on the current path, the stock can de-rate despite looking optically cheap on forward earnings. Conversely, if management signals a plateau in spend or the next two quarters show incremental monetization from AI that lifts margins, the selloff could reverse quickly because the multiple is already compressed.

Consensus is likely missing that this is less a valuation story than a capital allocation trust story. The current setup offers upside if management proves it can convert compute into durable incremental returns, but the burden of proof sits with execution, not narrative. In other words: the stock is cheap enough to own, but not yet cheap enough to ignore the funding risk embedded in the next 12-18 months.

Key Decisions for Investors

• META: initiate a starter long only on weakness, sized as a 0.5-1.0% portfolio position, with a 6-12 month horizon. Risk/reward favors upside if management pauses capex escalation, but the position should be capped because free-cash-flow compression can keep the stock range-bound.
• META / NVDA pair: long META, short a small basket of AI capex beneficiaries (preferably NVDA against a weaker hardware-exposed peer if available) into any post-earnings relief rally. The thesis is that the market is already paying for infrastructure demand, while META’s own stock is discounting the spend before the monetization is fully visible.
• Own META via call spreads rather than outright equity for a 3-6 month catalyst window. Use a modest upside structure to express the view that multiple compression is already largely priced, while limiting damage if capex guidance is raised again.
• Avoid chasing NFLX or other ad-light growth names as a hedge; they do not directly offset the specific risk here. If anything, use META’s strength as a source of funds for cleaner FCF stories that are not hostage to capex revisions.
• Set a tactical add point only if management demonstrates two consecutive quarters of stable or falling capex intensity relative to revenue. Until then, treat rallies as valuation-driven rather than conviction-driven, and take partial profits into sharp rebounds.